Español
PrintEmail
Decrease (-) Restore Default Increase (+)
In This Section Texas Health Research & Education Institute

Clinical Trials

Disease or Condition   Heart / Stent
Title   Evaluation of drug (Everolimus) coated stent (Heart / Stent)
Description   The primary objective of this study is to evaluate clinical outcomes in patients who receive the FDA-approved XIENCE V Everolimus Eluting Coronary Stent System (EECSS) over a five year period post surgery.
IRB Number   Pro239
Inclusion/Notes   INCLUSION:
  • Patients who understand English and receive only XIENCE V EECSS stent(s).

EXCLUSION:
  • Patients who don’t understand English and patients who receive other types of stents.
Status   Active - not Recruiting
Location   Texas Health Presbyterian Hospital Dallas
Principal Name    Vinit Rashbihari Lal MD
Contact Name   Shelley Long
Phone   (214) 345-8131

Online Tools

Locations

Helpful Info

Links